Expert: What’s in store this year for the technology, media, and telecom industries in Houston

Guest column

Trends in the TMT industry were largely driven by the disruptions related to COVID-19, but disruption also brings innovation and opportunity. Photo via Getty Images

As the new year begins, the impact of the pandemic and what it means for the future remains top-of-mind. COVID-19 has been a catalyst that has fostered change in many industries, including technology, media, and telecommunications (TMT). It's accelerated several trends such as the adoption of cloud technology, telehealth, and remote healthcare, and the intelligent edge.

In Deloitte's 2021 TMT predictions report, we highlight how worldwide trends could affect stakeholders and consumers across the globe. Here in Houston, we see the below trends as especially relevant for the year ahead.

Cloud technology and AI’s significant role

The evolution of instrumentation, automation and connectivity have led us to the "intelligent edge" – a new stage where the combination of advanced wireless connectivity, compact processing power and artificial intelligence have converged. Cloud computing, data analytics and AI are physically closer in the intelligent edge so that data can be rapidly analyzed and acted upon.

In 2021, Deloitte predicts the global market for the intelligent edge will expand to 12 billion, continuing a compound annual growth rate of around 35 percent. With this in mind, this type of technology can play a significant role across the industrial sector in terms of efficiencies and emissions reductions; many Houston companies are already leading in this space.

Additionally, Deloitte predicts that revenue growth will remain at or above 2019 levels (greater than 30 percent) for 2021 through 2025, largely driven by companies that are moving to the cloud in an effort to save money, become more agile and drive innovation. The maturation of the cloud industry during the pandemic has demonstrated resilience and we expect companies to continue to rely more heavily on the cloud in 2021.

Athletes by the numbers

Houstonians are some of the country's biggest sports fans, and in this era of the hyper-quantified athlete, data collection in sports is more prominent than ever.

The digital transformation of sports is in full swing and with it comes the explosion of data. Data collection – through video analytics, wearables, and smart fabrics – and how it is used raises new questions about data privacy for athletes. Deloitte predicts that by the end of 2021, multiple professional sports leagues will establish new formal policies around the collection, use and commercialization of player data.

Additionally, as seen in recent years, the use of high tech will also force teams to be more competitive, which may push boundaries and challenge our ideas about traditional sports.

Our new virtual reality

Last year, the pandemic halted in-person teaching and learning for many local educators and students. In addition, some Houston-based companies had to rethink their approach to onboarding new employees and skills training.

Some companies relied on virtual reality, augmented reality, and mixed reality solutions. These digital reality experiences helped simulate an in-person environment, which created a 50 percent spending increase on AR and VR headsets, software, and services. In 2021, sales for enterprise and educational use of wearable headsets for VR, AR, and MR could grow by 100 percent over 2019 levels.

COVID-19 also brought many industries online, including medicine. Deloitte projects the percentage of total virtual doctors' visits will rise to 5 percent globally in 2021. This means more potential business for the companies providing technologies to support virtual visits. We can also expect that the market for pure-play telehealth virtual visit solutions will reach $8 billion this year. And, we predict that more than $3 billion of medical-grade home health care technology will be sold in 2021, which represents an increase of almost 20 percent over 2019. Houston is already home to the world's largest medical center (Texas Medical Center) and we will likely see its footprint soar in 2021.

These trends in the TMT industry were largely driven by the disruptions related to COVID-19, but disruption also brings innovation and opportunity. As the world continues to wrestle in the grip of a global pandemic, there will likely be further implications that may affect TMT businesses and consumers worldwide and here in our hometown, Houston. To keep apprised of the latest trends, follow us on Twitter @DeloitteTMT.

------

Nate Clark is the U.S. Oil, Gas & Chemicals Digital Practice Leader at Deloitte Consulting LLP. This publication contains general information only and Deloitte is not, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

How a Houston company is fighting anxiety, insomnia & Alzheimer’s through waveforms

mental health

A Houston-based company is taking a medicine-free approach to target brain neurologically associated with mental illness.

Nexalin Technology’s patented, FDA-cleared frequency-based waveform targets key centers of the midbrain to support the normalization of neurochemicals through a process known as Transcranial Alternating Current Stimulation (tACS). Delivered via a non-invasive device, the treatment gently stimulates the hypothalamus and midbrain, helping to “reset networks associated with symptoms” of anxiety and insomnia. Early clinical evidence suggests this approach can promote healthier brain function and improved sleep.

Through its recently appointed scientific advisory board (SAB), Nexalin also aims to target Alzheimer’s disease with a clinical development pipeline supported by published data and internal data from studies involving its proprietary DIFS technology. Nexalin’s Gen-2 SYNC and Gen-3 Halo headset delivers the DIFS, which is a waveform that can penetrate deep brain structures implicated in cognitive decline and mental illness.

The board includes experts in neurology, neuroimaging and neurodegenerative diseases with Dr. Mingxiong Huang, Dr. David Owens, and Dr. Abe Scheer coming on board. Nexalin plans to initiate new Alzheimer’s-focused clinical studies in the Q3 2025 by incorporating cognitive testing, imaging biomarkers, and guided metrics to assess treatment efficacy and neural activation.

“I am excited to work alongside Nexalin’s leadership and fellow SAB members to help guide the next generation of non-invasive neuromodulation therapies,” Huang said in a news release. “The intersection of neuroimaging, brain stimulation, and clinical science holds enormous potential for treating neurodegenerative disease.”

Recently, Nexalin’s proprietary neurostimulation device moved forward with a clinical trial that evaluated its treatment of anxiety disorders and chronic insomnia in Brazil. The first of Nexalin’s Gen-2 15-milliamp neurostimulation devices was shipped to São Paulo, Brazil, and the study will be conducted at the Instituto de Psiquiatria University Hospital (IPq-HCFMUSP). The shipments aim to support the launch of a Phase II clinical trial in adult patients suffering from anxiety and insomnia. The Nexalin Gen-2 15-milliamp neurostimulation device has also been approved in China, Brazil and Oman. Its Gen 1 device first received FDA clearance in 2003, according to the company's website.

The company also enrolled the first patients in its clinical trial at the University of California, San Diego, in collaboration with the VA San Diego Healthcare System for its Nexalin HALO, which looks to treat mild traumatic brain injury and post-traumatic stress disorder in military personnel and the civilian population.

Nexalin previously raised $5 million through a

public stock offering.

Houston innovation hub announces first cohort for energy-focused accelerator

Powering Up

Energytech Nexus, a Houston-based hub for energy startups, has named its inaugural cohort of 14 companies for the new COPILOT accelerator.

COPILOT partners with Browning the Green Space, a nonprofit that promotes diversity, equity and inclusion (DEI) in the clean energy and climatech sectors. The Wells Fargo Innovation Incubator (IN²) at the National Renewable Energy Laboratory backs the COPILOT accelerator.

The eight-month COPILOT program offers mentorship, training and networking for startups. Program participants will be tasked with developing pilot projects for their innovations.

Two Houston startups are members of the first COPILOT class:

  • GeoFuels, housed at Houston’s Greentown Labs, has come up with a novel approach to hydrogen production that relies on geothermal power and methane decomposition.
  • PolyQor, which converts plastic waste into eco-friendly construction materials. Its flagship EcoGrete product is an additive for concrete that enhances its properties while reducing carbon emissions. PolyQor’s headquarters is at Houston’s Greentown Labs.

Other members of the COPILOT cohort are:

  • Birmingham, Alabama-based Accelerate Wind, developer of a wind turbine for commercial buildings.
  • Ann Arbor, Michigan-based Aquora Biosystems, which specializes in organic waste biorefineries.
  • Phoenix-based EarthEn Energy, a developer of technology for thermo-mechanical energy storage.
  • New York City-based Electromaim, which installs small hydro-generators in buildings’ water systems.
  • Chandler, Arizona-based EnKoat, an advanced materials company whose flagship product, the IntelliKoat System, is a patented two-layer thermal and weather barrier roof coating for flat and low-slope commercial buildings.
  • Calgary, Canada-based Harber Coatings, which manufactures electroless nickel coating and electroless nickel plating.
  • Dallas-based Janta Power, which designs and makes 3D solar towers.
  • Miami-based NanoSieve, a developer of gas remediation technology.
  • Palo Alto, California-based Popper Power, which has developed a platform that turns streetlight networks into resilient, maintenance-free distributed charging infrastructure.
  • Buffalo, New York-based Siva Powers America, developer of small wind turbines for farms, utility companies and others with annual energy needs of 300,000 to 2 million kilowatt-hours.
  • Los Angeles-based Thermoshade, which specializes in cooling panels for outdoor environments.
  • Waukesha, Wisconsin-based V-Glass, Inc., developer of a vacuum-insulated glass for affordable high-efficiency windows.

“These startups reflect the future of energy access and resilience innovation,” said Juliana Garaizar, founding partner of Energytech Nexus. “By connecting them directly with partners through COPILOT, we’re helping them overcome the ‘pilot gap’ to build solutions that scale.”

The startups will run pilot projects along the Gulf Coast for their inventions.

Rice University's top innovation exec leaving for new role at UVA

moving on

Paul Cherukuri, Rice University's top innovation executive, responsible for some of Rice’s major innovative projects like the Rice BioTech LaunchPad and Rice Nexus, will leave the university next month to accept a position at the University of Virginia.

Cherukuri, Rice’s first vice president for innovation and chief innovation officer, will become the University of Virginia’s Donna and Richard Tadler University Professor of Entrepreneurship and the school's first chief innovation officer, according to a release from Rice. Cherukuri, who has served for more than 10 years at Rice, plans to depart his current position on Sept. 30.

Adrian Trömel, associate vice president for innovation strategy and investments at Rice, will serve as interim vice president for innovation and chief innovation officer after Cherukuri departs, and as the university starts an international search for his replacement.

“We appointed Paul to build an ambitious and high-functioning innovation operation, and he has succeeded remarkably in short order,” Rice President Reginald DesRoches said in the release. “In every area, from technology translation and startup creation to commercialization and entrepreneurship training, he has led the effort to vastly improve our structure, operations and relationships. He has contributed immensely both to our strategies and their implementation across numerous areas, and we’ll miss him greatly.”

Cherukuri is a physicist, chemist and medical technology entrepreneur, and has been a member of DesRoches’ leadership team since 2022. Cherukuri served as executive director of Rice’s Institute of Biosciences and Bioengineering from 2016 to 2022, where he helped in the development of interdisciplinary translational research partnerships with federal and corporate agencies. His work helped earn nearly $37 million in funding for accelerating the development of new technologies into commercial products. In the energy transition field, Cherukuri led a $12.5 million partnership with Woodside Energy to transform greenhouse gases into advanced nanomaterials for next-generation batteries and transistors.

Initiatives the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion; were all launched under Cherukuri’s leadership. With his work at the Ion, Cherukuri also led the announcement of a partnership with North America’s largest climate tech incubator, Greentown Labs.

“I am proud of the relentless innovative spirit we have built for Rice in Houston and around the world,” Cherukuri said in the release. “I look forward to bringing new energy and vision to UVA’s efforts in this critical space for our country, its success and future.”

View All Listings